AGP Executive Report
Last update: 11 hours agoMedical Safety & Regulation: Boston Scientific is pulling certain Imager II angiographic catheters after a manufacturing issue that can raise the risk of tip detachment, with the FDA posting an early alert. Cybersecurity in Healthcare: McKesson says hackers exfiltrated data from cloud accounts, with claims tied to the ShinyHunters group and potential exposure of sensitive patient information. Biotech & Pharma Access: Canada’s CDA-AMC gave a final positive recommendation for public reimbursement of Eisai/Biogen’s LEQEMBI (lecanemab) for early Alzheimer’s, moving eligible patients closer to coverage. AI-Native Business: Parksy says it rebuilt its free, commission-free parking marketplace using AI coding agents and cross-checking models to keep listings current at global scale. Climate & Materials Science: Scientists report a new purple fabric for passive radiative cooling that can stay several degrees cooler in direct sun. Public Health & Policy: A CDC-linked analysis finds buprenorphine use remains underused, with pharmacy dispensing down since 2021 even as ED administration rose. Energy & Competitiveness: A U.S. National Petroleum Council push calls for faster, coordinated assessment of subsurface resources via a proposed national data portal.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
